Biotech Values

[semi_infinite]

RE "The MYOK trial you referred to is designed with FDA input and accepted by them ."

The phase 3 study (Explorer HCM) has not yet been described on the FDA clinical trial site. It will be interesting to see what the FDA wants and I expect to company will have something more concrete to say about that this week. The last update was in Nov.

https://globenewswire.com/news-release/2017/11/02/1173799/0/en/MyoKardia-Reports-Third-Quarter-2017-Financial-Results-and-Operational-Progress.html

ps I have a tiny option position, hedged.